Aligos Therapeutics Statistics

Total Valuation

ALGS has a market cap or net worth of $59.37 million. The enterprise value is -$65.27 million.

Market Cap	59.37M
Enterprise Value	-65.27M

Important Dates

The next estimated earnings date is Friday, May 10, 2024, after market close.

Earnings Date	May 10, 2024
Ex-Dividend Date	n/a

Share Statistics

ALGS has 72.58 million shares outstanding. The number of shares has increased by 50.51% in one year.

Shares Outstanding	72.58M
Shares Change (YoY)	+50.51%
Shares Change (QoQ)	+47.74%
Owned by Insiders (%)	21.07%
Owned by Institutions (%)	62.53%
Float	36.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.82
Forward PS	n/a
PB Ratio	0.64
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.90, with a Debt / Equity ratio of 0.12.

Current Ratio	5.90
Quick Ratio	n/a
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	70.90

Financial Efficiency

Return on equity (ROE) is -116.40% and return on invested capital (ROIC) is -85.38%.

Return on Equity (ROE)	-116.40%
Return on Assets (ROA)	-75.40%
Return on Capital (ROIC)	-85.38%
Revenue Per Employee	$235,288
Profits Per Employee	-$1.33M
Employee Count	66
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

In the past 12 months, ALGS has paid $795,000 in taxes.

Income Tax	795,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.58% in the last 52 weeks. The beta is 2.34, so ALGS's price volatility has been higher than the market average.

Beta (1Y)	2.34
52-Week Price Change	-20.58%
50-Day Moving Average	0.90
200-Day Moving Average	0.80
Relative Strength Index (RSI)	41.69
Average Volume (30 Days)	401,611

Short Selling Information

The latest short interest is 657,205, so 0.91% of the outstanding shares have been sold short.

Short Interest	657,205
Short Previous Month	868,831
Short % of Shares Out	0.91%
Short % of Float	1.79%
Short Ratio (days to cover)	1.68

Income Statement

In the last 12 months, ALGS had revenue of $15.53 million and -$87.68 million in losses. Loss per share was -$1.36.

Revenue	15.53M
Gross Profit	15.53M
Operating Income	-88.13M
Pretax Income	-86.88M
Net Income	-87.68M
EBITDA	-85.06M
EBIT	-88.13M
Loss Per Share	-$1.36

Full Income Statement

Balance Sheet

The company has $135.77 million in cash and $11.14 million in debt, giving a net cash position of $124.64 million or $1.72 per share.

Cash & Cash Equivalents	135.77M
Total Debt	11.14M
Net Cash	124.64M
Net Cash Per Share	$1.72
Equity / Book Value	92.08M
Book Value Per Share	1.27
Working Capital	117.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$79.00 million and capital expenditures -$19,000, giving a free cash flow of -$79.02 million.

Operating Cash Flow	-79.00M
Capital Expenditures	-19,000
Free Cash Flow	-79.02M
FCF Per Share	-$1.23

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -567.50% and -564.61%.

Gross Margin	100.00%
Operating Margin	-567.50%
Pretax Margin	-559.50%
Profit Margin	-564.61%
EBITDA Margin	-547.74%
EBIT Margin	-567.50%
FCF Margin	-508.83%

Dividends & Yields

ALGS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.51%
Shareholder Yield	-50.51%
Earnings Yield	-147.69%
FCF Yield	-133.10%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	84.11%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ALGS has an Altman Z-Score of -4.79 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.79
Piotroski F-Score	4